Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Catechol-O-methyltransferase polymorphism studied as predictor for breast cancer
October 6th, 2005
The catechol-O-methyltransferase polymorphism was studied by scientists in Japan as a predictor for breast cancer. "Polymorphic catechol-O-methyltransferase (COMT) catalyzes the O-methylation of catechol estrogens. It has been reported that COMT polymorphism is a representative genetic trait related to the susceptibility of an individual to breast cancer," according to a report published in Oncology Reports. "However, there is no consensus concerning the association between breast cancer in Japanese patients and COMT polymorphism," wrote H. Inoue and colleagues. "To analyze the polymorphism distribution in Japanese patients with breast cancer,...
Source: Women's Health Weekly (2005-10-06)
|
